1 Papillary thyroid carcinoma (PTC) etiologically occurs as a radiation-induced or sporadic malignancy. 2 Genetic factors contributing to the susceptibility to either form remain unknown. In this retrospective 3 case-control study we evaluated possible associations between single nucleotide polymorphisms (SNPs) 4 in the candidate DNA damage response genes (ATM, XRCC1, TP53, XRCC3, MTF1) and risk of 5 radiation-induced and sporadic PTC. A total of 255 PTC cases (123 Chernobyl radiation-induced and 132 6 sporadic, all in Caucasians) and 596 healthy controls (198 residents of Chernobyl areas and 398 subjects 7 without history of radiation exposure, all Caucasians) were genotyped. The risk of PTC and SNPs 8 interactions with radiation exposure were assessed by logistic regressions. The ATM G5557A and XRCC1 9 Arg399Gln polymorphisms, regardless of radiation exposure, associated with a decreased risk of PTC 10 according to the multiplicative and dominant models of inheritance (OR=0.69, 95% CI 0.45-0.86 and 11 OR=0.70, 95% CI 0.59-0.93, respectively). The ATM IVS22-77 T>C and TP53 Arg72Pro SNPs 12 interacted with radiation (P=0.04 and P=0.01, respectively). ATM IVS22-77 associated with the increased 13 risk of sporadic PTC (OR=1.84, 95% CI 1.10-3.24) whereas TP53 Arg72Pro correlated with the higher
Introduction
1 Thyroid cancer accounts for more than 90% of all endocrine malignancies. The incidence of 2 thyroid cancer in the world is increasing during the past three decades, mainly due to the papillary thyroid 3 carcinoma (PTC) which is the predominant type of malignant thyroid tumors (Davis & Welch 2006) .
4
The vast majority of Chernobyl thyroid malignancies were PTCs which displayed wide variations 1 in clinical course, from highly aggressive tumors developing after the shorter latency to more indolent 2 carcinomas with the longer latent period (Williams 2006) . The randomness and multiplicity of forms of 3 genetic alterations caused by IR can only partly explain these differences in the individual reactions on 4 exposure as well as why cancer develops only in some of exposed individuals.
5
It is attractive to hypothesize that inherited variability in the genes directly or indirectly involved 6 in the maintenance of genome stability in response to environmental carcinogens such as IR or chemicals 7 may play a role in susceptibility for radiation-related or sporadic PTC or may be a marker of it. In this 8 work we tested the relation of genetic variants of some of such genes, namely ATM, TP53, XRCC1, 9 XRCC3 and MTF1, to PTC of different etiology.
10
The Ataxia-telangiectasia mutated (ATM) gene plays a key role in the sensing and repair of DNA 11 double-strand breaks. Activation of the ATM protein kinase by IR results in the subsequent initiation of 12 several molecular pathways of DNA damage repair (Shiloh 2003) . One of the ATM targets is the p53 13 pathway. Overexpression of TP53 arrests the cell cycle and affects DNA repair and apoptosis. 14 The ATM and TP53 genes play a significant role especially in the tumors that are induced by IR.
15
A number of single nucleotide polymorphisms (SNPs) in the ATM and TP53 genes studied in populations 16 of different ethnicities have been reported to associate with the risk of different radiogenic tumors (Hu et 17 al. 2002; Angele et al. 2003; Thorstenson et al. 2003; Malmer et al. 2007) . In contrast, studies of post-
18
Chernobyl pediatric thyroid cancers demonstrated a low mutation and polymorphism rate in the TP53 19 gene (Nikiforov et al. 1996; Hillebrandt et al. 1997) . It, however, should be mentioned that after exposure 20 to radiation p53 facilitates DNA repair in normal thyrocytes in vitro (Yang et al. 1997 ).
21
The base excision repair (BER) and homologous recombination repair (HRR) pathways are 22 particularly important for genomic integrity restoration (Hoeijmakers 2001) . The product of the X-ray 23 repair cross complementing 1 (XRCC1) gene acts as a scaffold and a modulator of different enzymes 24 involved in BER. The XRCC1 Arg399Gln and Arg280His variants have been extensively investigated for 25 their function and association with cancer risk; however, the results remain contradictory rather than 5 conclusive (Hu et al. 2005) . The XRCC3 gene is a member of the Rad51 DNA-repair gene family. Its 1 product is a factor of the HRR. The XRCC3 Thr241Met polymorphism has been controversially 2 associated with different human malignancies (Han et al. 2006) . Sturgis et al. (2005) reported 241Met 3 allele association with the risk of differentiated thyroid cancer .
4
The Metal-responsive transcription factor1 (MTF1) gene has been implicated in tumor initiation 5 and progression to malignant growth. MTF1 protein interacts with metallothioneins that are able to 6 suppress cellular stresses generated by IR and other agents (Tamura et al. 2005) . Polymorphism in murine 7 Mtf1 gene has been found to associate with the susceptibility to experimental γ-ray-induced thymic 8 lymphomas. This observation points at possible involvement of human MTF1 polymorphisms in the 9 modulation of radiation-induced malignancies (Tamura et al. 2005) .
10
To date no polymorphisms of the ATM, XRCC1 and MTF1 genes have been studied neither in 11 human sporadic or radiation-induced PTCs. Data on the TP53 and XRCC3 polymorphisms associations 12 are quite limited (Hillebrandt et al. 1997; Boltze et al. 2002; Granja et al. 2004; Sturgis et al. 2005;  13 Rogounovitch et al. 2006 studies (Davis et al. 2004; Stepanenko et al. 2004) . The doses varied from 43 to 2640 mGy. Radiation 6 thyroid doses for PTC patients and controls from Belarus evaluated in dosimetric investigations at the 1 places of residence ranged 21-1500 mGy (Bouville et al. 2007 ). Among the controls, 198 individuals (65 2 males and 133 females, mean age at sampling 22.2 ± 3.2 years old; 19-35 years old, range) were residents 3 of the Chernobyl areas (60 from the Russian Federation and 138 from Belarus). The averaged thyroid 4 radiation dose in the exposed control subjects from Russia is 41 mGy (Bouville et al. 2007 ). All exposed 5 control individuals were aged less than 18 years at the time of the accident (mean age at exposure 1.8 ± 6 3.2 years old; 1-16 years old, range) (IR-exposed controls). IR-exposed controls and patients with IR-7 induced PTCs not were individually matched; however, they were residents of the same settlements. This, 8 given the uncertainty with individual radiation thyroid doses, was supposed to partly reduce exposure bias.
9
Age of IR-exposed control subjects was set to be ± 3 years of that of IR-induced PTC individuals.
10
One hundred and thirty-two PTC cases (21 males and 111 females, mean age at diagnosis 47.8 ± 11 11.4 years old; 19-76 years old, range) were adults without history of radiation exposure (sporadic PTCs).
12
The remaining 398 control participants (180 males and 218 females, mean age at sampling 45.0 ± 10.3 13 years old; 16-65 years old, range) had no previous history of radiation exposure (non-exposed controls); 14 their age was also set to be ± 3 years of that of patients with sporadic PTC. Both sporadic PTCs and non-15 exposed controls originated from the European part of Russia not contaminated by the Chernobyl fallouts.
16
Thyroid tissues and/or blood samples were collected from patients during surgery or further 17 follow-up. Blood samples and information from the controls were obtained during a routine health 18 examination or complex screening for thyroid diseases.
19
Written informed consent was obtained from all participants. Protocols of the present study were 20 approved by the Committee for Ethical Issues of Human Genome Analysis of Nagasaki University. 
20
The distribution of genotypes and MAF for each SNP in the four study groups is shown in Table   21 3. The observed distributions in the control groups were not statistically different from those expected 22 from Hardy-Weinberg equilibrium for all SNP except for ATM G5557A and ATM IVS22-77 T>C in the 23 non-exposed controls. Since such deviation might point at possible genotyping error (Hosking et al. 2004 ),
24
we reanalyzed 96 non-exposed controls for these SNPs by direct sequencing. There were no 25 inconsistencies between PCR/RFLP and sequencing results (data not shown) ruling out technical flaw.
9
Furthermore, allelic frequencies determined in our study are in a good agreement with those specified for 1 Caucasians in the dbSNP (build 129, April 2008, Table 1 ) thus attesting to the appropriate data quality.
2
As seen from Table 4 , an association between ATM G5557A and PTC, regardless of radiation 3 exposure, was found. The presence of the A allele significantly decreased PTC risk compared with wild-4 type G allele in the multiplicative model of inheritance (OR=0.69, 95% CI 0.45-0.86, P=0.03), which is 5 useful for risk comparison between the groups based on the analysis of allelic frequencies in them.
6
Main effect on PTC risk appeared also significant for the XRCC1 gene Arg399Gln polymorphism.
7
The presence of the minor 399Gln allele decreased PTC risk compared with the Arg/Arg genotype 8 (OR=0.66, 95% CI 0.57-0.88, P=0.02 and OR=0.70, 95% CI 0.59-0.93, P=0.03, in the co-dominant and 9 dominant models, respectively).
10
Analysis of combined ATM G5557A and XRCC1 Arg399Gln genotypes demonstrated that 11 increasing number of minor alleles (i.e. ATM 5557A and XRCC1 399Gln) significantly decreased PTC 12 risk in corresponding individuals in comparison with those who do not carry minor alleles (Fig. 1 ).
13
No other SNP in any gene showed a significant main effect on PTC.
14 For ATM IVS22-77 T>C and TP53 Arg72Pro, evidence for interaction between radiation 15 exposure and PTC was found (P for interaction 0.04 and 0.01, respectively). As shown in Table 5 , the 16 analyses performed in IR-exposed and non-irradiated patients compared, respectively, with irradiated and 17 non-exposed controls revealed a significantly increased risk of sporadic PTC for the ATM IVS22-77 18 homozygous CC genotype carriers compared with the TC+TT genotypes (the recessive model of 19 inheritance, OR=1.84, 95% CI 1.10-3.24, P=0.03), whereas in the irradiated group an insignificant 20 inverse effect of these genotypes was observed (OR=0.59, 95% CI 0.28-1.27, P=0.17). For TP53 codon 21 72 polymorphism, in all but the recessive models the increased risk of IR-induced PTC as compared to 22 IR-exposed controls was observed. The highest risk of radiogenic PTC was in the co-dominant model 23 (OR=2.33, 95% CI 1.15-7.21, P=0.03). A significant risk was also found in the multiplicative model of 24 inheritance (OR=1.70, 95% CI 1.17-2.46, P=0.006). In addition, comparison between IR-exposed and 25 non-exposed controls did not reveal statistically significant difference in adjusted distributions of these 10 polymorphisms. In healthy subjects the strongest association for the ATM IVS22-77 T>C was in the 1 recessive model (OR=1.38, 95% CI 0.84-2.26, P=0.21) and in the multiplicative model for TP53 2 Arg72Pro (OR=0.70, 95% CI 0.52-1.19, P=0.11) further emphasizing possible role of these SNPs in PTC 3 of different etiology.
4
Considering multiple pathways for repairing diverse DNA damages induced by endogenous and 5 exogenous carcinogens, genetic variants in different repair pathways may probably have a joint effect on 6 cancer risk. In attempt to search for the stronger associations between PTC and studied SNPs, we 7 performed the analyses of genotype combinations for the ATM and TP53 polymorphisms as these genes 8 are functionally related and 3 of 4 SNPs included in our study showed effects on PTC. Among the 9 possible ATM/TP53 combinations (rs1801516/rs664677/rs609429/rs1042522) tested, two demonstrated 10 significant differences in the subsets of both groups of PTCs (Fig.2) . Particularly, the combined 11 ATM/TP53 GG/TC/CG/GC genotype was strongly associated with the IR-induced PTC (OR=2.10, 95% 12 CI 1.17-3.78, P=0.015). Another ATM/TP53 combination, GG/CC/GG/GG, demonstrated a significantly 13 increased risk for sporadic PTC (OR=3.32, 95% CI 1.57-6.99, P=0.002).
15

Discussion
16
Our study addressed possible associations between SNPs in the genes involved in DNA damage 17 response and the risk of PTC of different etiology. The results demonstrated that the presence of the 18 variant 5557A allele in exon 39 of ATM and XRCC1 399Gln allele, particularly in the heterozygous state, 19 significantly associated with the decreased risk of PTC. The ATM IVS22-77 CC genotype in the non-20 exposed group and the TP53 72Pro allele in the radiation-related one associated with the increased risk of 21 PTC. Moreover, two particular ATM/TP53 combined genotypes were found with higher frequencies in the IR-induced or sporadic PTC when compared to the controls. Altogether, these data indicate that SNPs in 23 the studied genes may likely modify PTC risk.
24
A significant association between the ATM G5557A and bilateral breast cancer in Caucasian 25 patients has been shown before (Heikkinen et al. 2005) . Also, this SNP has been reported as a possible 11 modulator of clinical radiosensitivity in cancer. The ATM 5557A allele was associated with severe 1 adverse effects of radiation therapy in prostate (Hall et al. 1998) 14 was somewhat, but insignificantly, higher as compared to sporadic PTCs (Table 3 ). The results for the 15 IVS48 + 238 C>G tended to parallel those for the IVS22-77 T>C remaining below the threshold of 16 significance. At present, the mechanistic and functional basis for the intronic ATM SNPs implications in 17 cancer revealed in the previous studies and in ours as well is not fully understood. In a broader sense, 18 however, they may be indicative of a role for the ATM gene (or its product) in the development of PTC.
19
As reviewed by Hu et al. (2005) , the results of the XRCC1 gene Arg399Glu investigations vary in 20 different cancers for populations with different ethnicities. In relation to cancer and radiation, the 399Gln 21 allele in combination with 280His was associated with breast cancer risk, and in pair with 194Trp with 22 clinical radiosensitivity in Caucasian women with breast cancer. Also, the 399Gln allele was found to 23 decrease the risk of bladder cancer and squamous cell carcinoma of the head and neck.
24
Interestingly, not only variant, but also wild-type allele (i.e. XRCC1 399Arg) demonstrated 25 possible role in cancer. High-dose radiation to the chest was more strongly associated with breast cancer 12 among white American women with XRCC1 Arg399Arg genotype (Duell et al. 2001) . Looking for 1 potential biological explanations for these findings, the authors found a higher prevalence of TP53 2 deletions in the Arg399Arg cases exposed to occupational radiation compared with exposed patients with 3 the Gln399Gln genotypes or unexposed cases of either genotype. Figueiredo et al. (2004) observed an 4 increased risk of disease among wild-type homozygous (Arg/Arg) and heterozygous Canadian Caucasian 5 women with a family history of breast cancer compared to the individuals without such.
6
The described above data may be explained, at least in part, by the results of functional study of 7 this polymorphism in which an equal ability for both alleles to suffice single strand break repair by 8 XRCC1 has been found (Taylor et al. 2002) . The results of our study, taken together with those reported 9 previously, suggest that XRCC1 polymorphism, in particular the Arg399Gln genotype, may influence 10 PTC risk, perhaps by modifying the effects of environmental exposure and/or through interaction with 11 other genetic factors.
12
The TP53 
8
It is necessary to note that even though 9 SNPs were analyzed in our study, no correction for 9 multiple comparisons was applied because of study design and techniques employed. The associations 10 were tested in a one-at-a-time fashion in a limited sample size in the difficult to access groups. The need 11 for correction in such circumstances is still debated (Rothman & Greenland 1998). Furthermore, since 12 data obtained in this work may be referred to as an initial screening result, non-adjusted presentation 13 enables their inclusion in future meta-analysis. Effects of candidate SNPs which we report need validation 14 in other studies.
15
In conclusion, the results presented here show that SNPs in ATM exon 39 and XRCC1 exon 10 16 may be the markers of a decreased PTC risk in adults, whereas the ATM IVS22-77 and TP53 codon 72 17 SNPs genes may associate with the risk of PTC development in non-irradiated and irradiated individuals.
18
To the best of our knowledge, presented here is the first study of this kind reporting the results of 19 genotyping of candidate DNA damage response genes in irradiated and non-irradiated PTC patients and 20 in corresponding healthy populations. Our data support the paradigm of genetic modifiers of radiation-21 associated carcinogenesis and perhaps may contribute to genetic determination of PTC-prone subjects.
22
We believe such identification will allow future personalized cancer risk prediction which is of a 23 significant importance in view of the growing thyroid cancer incidence and also because of the relevance 24 to occupational and radiation emergency medicine issues. genotypes were analyzed separately in the IR-exposed and sporadic PTCs vs. corresponding control. Six combinations of 3 ATM and 1 TP53 SNPs (rs1801516/rs664677/rs609429/rs1042522) whose frequencies were higher than 5% at least in two of four subgroups are shown. In the numerical codes for any SNP, 0the genotype with no MA (i.e. homozygous wild-type); 1 -1 MA presents (heterozygous genotype); 2 -2 MA present (homozygous variant genotype); first 3 numbers correspond to 3 ATM SNPs and the last one to TP53 polymorphism. In the figure, the GG/TT/CC/GG genotype is represented by the "0000" numerical code as it does not contain minor alleles; the GG/TC/CG/GG corresponds to 0110, GG/TC/CG/GC to 0111; GG/CC/GG/GC to 0221; GA/TC/CG/GG to 1110 and GG/CC/GG/GG to 0220.
Figure legends
All combinations with frequencies less than 5% in three or more subgroups are pooled and indicated as "other". 
